Literature DB >> 18817830

CD8+ suppressor T cells resurrected.

Judith A Kapp1, R Pat Bucy.   

Abstract

This review focuses on the role of antigen-specific T cells that mediate active inhibition of immune responses over the past 35 years since their initial description. The field has experienced several changes in the accepted paradigm of such suppressor/regulatory T cells, from initial indications that such cells were CD8(+), to the view that such cells did not exist, to the identification of the transcription factor Foxp3 as a key orchestrator of inhibitory function. Although most Foxp3(+) cells in a resting animal are CD4(+)CD25(+) cells, Foxp3 expression and inhibitory function can be induced by antigens in the periphery by selective cytokine conditions, particularly TGF-beta. Such induced T cells occur within both the CD4 and the CD8 T-cell lineages and appear to mediate suppression by inhibiting the costimulatory activity of antigen-presenting cells and the production of inhibitory cytokines. Recent data generated by analysis of TCR Tg T cells that do not select many Foxp3-positive cells during thymic development are reviewed, emphasizing the pattern of "linked suppression" and focus of the relative potency of different mechanisms of suppression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817830     DOI: 10.1016/j.humimm.2008.07.018

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  24 in total

1.  Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD.

Authors:  Norifumi Sawamukai; Atsushi Satake; Amanda M Schmidt; Ian T Lamborn; Priti Ojha; Yoshiya Tanaka; Taku Kambayashi
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

2.  Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells.

Authors:  Ya Liu; Qin Lan; Ling Lu; Maogen Chen; Zanxian Xia; Jilin Ma; Julie Wang; Huimin Fan; Yi Shen; Bernhard Ryffel; David Brand; Francisco Quismorio; Zhongmin Liu; David A Horwitz; Anping Xu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2013-07-15       Impact factor: 6.216

3.  Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice.

Authors:  Jennifer Nancy Hahn; Vincent George Falck; Frank Robert Jirik
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

4.  Working toward immune tolerance in lung transplantation.

Authors:  Xinguo Jiang; Mark R Nicolls
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

5.  Mutual interaction between BCL6 and microRNAs in T cell differentiation.

Authors:  Zhiyuan Wei; Weiwu Gao; Yuzhang Wu; Bing Ni; Yi Tian
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

6.  CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells.

Authors:  Masakatsu Suzuki; Ann L Jagger; Christine Konya; Yasuhiro Shimojima; Sergey Pryshchep; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Immunol       Date:  2012-07-20       Impact factor: 5.422

Review 7.  Regulatory T cells essential to prevent the loss of self-tolerance in murine models of erythrocyte-specific autoantibody responses.

Authors:  Catherine E Calkins
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

Review 8.  LAG-3 in Cancer Immunotherapy.

Authors:  Monica V Goldberg; Charles G Drake
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

9.  Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Authors:  David A Horwitz; Stephanie Pan; Jing-Ni Ou; Julie Wang; Maogen Chen; J Dixon Gray; Song Guo Zheng
Journal:  Clin Immunol       Date:  2013-08-20       Impact factor: 3.969

10.  Regulation of tumor immune surveillance and tumor immune subversion by tgf-Beta.

Authors:  Hae-Young Park; Lalage M Wakefield; Mizuko Mamura
Journal:  Immune Netw       Date:  2009-08-31       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.